|
PSMA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.699400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.177900E-03 |
| Normal-vs-Stage2 |
8.421600E-02 |
| Normal-vs-Stage3 |
7.081200E-01 |
| Normal-vs-Stage4 |
6.258700E-03 |
| Stage1-vs-Stage2 |
5.708800E-01 |
| Stage1-vs-Stage3 |
1.640960E-01 |
| Stage1-vs-Stage4 |
2.152200E-01 |
| Stage2-vs-Stage3 |
1.783770E-01 |
| Stage2-vs-Stage4 |
7.585400E-01 |
| Stage3-vs-Stage4 |
4.860000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.423900E-03 |
| Normal-vs-AfricanAmerican |
9.179400E-01 |
| Normal-vs-Asian |
3.545400E-01 |
| Caucasian-vs-AfricanAmerican |
2.622400E-02 |
| Caucasian-vs-Asian |
6.465600E-01 |
| AfricanAmerican-vs-Asian |
1.615650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.336900E-03 |
| Normal-vs-Female |
1.205990E-01 |
| Male-vs-Female |
1.989430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.050400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.117700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.130200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.071600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.771000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.481000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.878000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.210600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.358400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.989200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.092000E-01 |
| Normal-vs-Grade 2 |
5.936100E-03 |
| Normal-vs-Grade 3 |
2.319600E-02 |
| Normal-vs-Grade 4 |
3.299200E-01 |
| Grade 1-vs-Grade 2 |
6.868300E-02 |
| Grade 1-vs-Grade 3 |
1.213590E-01 |
| Grade 1-vs-Grade 4 |
3.097000E-01 |
| Grade 2-vs-Grade 3 |
5.834600E-01 |
| Grade 2-vs-Grade 4 |
5.527000E-01 |
| Grade 3-vs-Grade 4 |
7.789000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.282750E-03 |
| Normal-vs-ccB subtype |
3.009000E-01 |
| ccA subtype-vs-ccB subtype |
1.047760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.816700E-03 |
| Normal-vs-N1 |
4.469600E-01 |
| N0-vs-N1 |
9.621400E-01 |
|
|
